Skip to main content

Table 3 Comparison of the Pfizer and AstraZeneca vaccination centers during the vaccination process*

From: Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study

Quartile

Range

Pfizer, N (%)

AstraZeneca, N (%)

P-value

Transportation

> 75

20 (100.0)

13 (100.0)

–

Handling and storage

50–75

2 (10.0)

1 (7.7)

1.000

> 75

18 (90.0)

12 (92.3)

Vaccine preparation

< 50

1 (5.0)

0

0.798

50–75

3 (15.0)

3 (23.1)

> 75

16 (80.0)

10 (76.9)

Pfizer preparation

50–75

4 (20.0)

–

–

> 75

16 (80.0)

–

AstraZeneca preparation

> 75

–

13 (100.0)

–

Pre-vaccination

< 50

2 (10.0)

2 (15.4)

0.413

50–75

0 (0.0)

1 (7.7)

> 75

18 (90.0)

10 (76.9)

Administration

> 75

20 (100.0)

13 (100.0)

–

Post-vaccination

50–75

3 (15.0)

3 (23.1)

0.659

> 75

17 (85.0)

10 (76.9)

Total

> 75

20 (100.0)

13 (100.0)

–

  1. *Statistical tests used included Pearson’s Chi-squared test or Fisher’s exact test